Diana Frances Clarke, Pharm.D.

Assistant Professor, Pediatrics

Diana Clarke
617.638.5300
72 E. Concord St Instructional (L)

Biography

Diana Clarke, PhD is an Assistant Professor of Pediatrics in Infectious Diseases at the Boston University School of Medicine. She originally earned a doctorate of pharmacy and worked as an assistant professor as well as a clinical pharmacist before adjuncting as an instructor of pediatrics at the Boston University School of Medicine for one year. After 26 years of working in the industry, she was hired as an Assistant Professor at BUSM, but still continues to work as a research pharmacist at BMC. Her commitment to pediatrics is demonstrated through her 12 year membership to the WHO Pediatric Antiretroviral Working Group and her past experience as the Vice Chair of the Pharmacy Resource Committee in the International Maternal Pediatric-Adolescent AIDS Clinical Trials Network Group.

Education

  • University of Rhode Island College of Pharmacy, BS
  • State University of New York at Buffalo, PharmD

Publications

  • Published on 3/15/2018

    Schreiner CN, Ahlfors CE, Wong RJ, Stevenson DK, Clarke DF, Mirochnick M. In Vitro Study on the Effect of Maraviroc or Dolutegravir on Bilirubin to Albumin Binding. Pediatr Infect Dis J. 2018 Mar 15. PMID: 29561509.

    Read at: PubMed
  • Published on 11/8/2017

    Clarke DF, Penazzato M, Capparelli E, Cressey TR, Siberry G, Sugandhi N, Mirochnick M. Prevention and treatment of HIV infection in neonates: evidence base for existing WHO dosing recommendations and implementation considerations. Expert Rev Clin Pharmacol. 2018 Jan; 11(1):83-93. PMID: 29039686.

    Read at: PubMed
  • Published on 1/1/2017

    Clarke DF, Yildirim I, Cooper ER. Rapid Initiation of Antiretrovirals in Two Newly Diagnosed HIV-infected Infants. Pediatr Infect Dis J. 2017 Jan; 36(1):61-62. PMID: 27749654.

    Read at: PubMed
  • Published on 11/1/2014

    Clarke DF, Acosta EP, Rizk ML, Bryson YJ, Spector SA, Mofenson LM, Handelsman E, Teppler H, Welebob C, Persaud D, Cababasay MP, Wang J, Mirochnick M. Raltegravir pharmacokinetics in neonates following maternal dosing. J Acquir Immune Defic Syndr. 2014 Nov 1; 67(3):310-5. PMID: 25162819.

    Read at: PubMed
  • Published on 9/1/2013

    Clarke DF, Wong RJ, Wenning L, Stevenson DK, Mirochnick M. Raltegravir in vitro effect on bilirubin binding. Pediatr Infect Dis J. 2013 Sep; 32(9):978-80. PMID: 23470680.

    Read at: PubMed
  • Published on 2/23/2011

    Mirochnick M, Clarke D. Oseltamivir pharmacokinetics in pregnancy: a commentary. Am J Obstet Gynecol. 2011 Jun; 204(6 Suppl 1):S94-5. PMID: 21640232.

    Read at: PubMed
  • Published on 12/1/2010

    Mirochnick M, Best BM, Clarke DF. Antiretroviral pharmacology: special issues regarding pregnant women and neonates. Clin Perinatol. 2010 Dec; 37(4):907-27, xi. PMID: 21078458.

    Read at: PubMed
  • Published on 10/1/2000

    Mirochnick M, Clarke DF, McNamara ER, Cabral H. Bioequivalence of a propylene glycol-based liquid dapsone preparation and dapsone tablets. Am J Health Syst Pharm. 2000 Oct 1; 57(19):1775-7. PMID: 11030029.

    Read at: PubMed
  • Published on 10/1/2000

    Mirochnick M, Clarke DF, Dorenbaum A. Nevirapine: pharmacokinetic considerations in children and pregnant women. Clin Pharmacokinet. 2000 Oct; 39(4):281-93. PMID: 11069214.

    Read at: PubMed
  • Published on 5/1/1993

    Mirochnick M, Michaels M, Clarke D, BreƱa A, Regan AM, Pelton S. Pharmacokinetics of dapsone in children. J Pediatr. 1993 May; 122(5 Pt 1):806-9. PMID: 8496767.

    Read at: PubMed

View all profiles